Frank Schroer

Person

Oxon, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Compounds having CRTH2 antagonist activity
- Patent number 8,980,927
- Issue date Mar 17, 2015
- Atopix Therapeutics Limited
- Richard Edward Armer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds having CRTH2 antagonist activity
- Patent number 8,563,536
- Issue date Oct 22, 2013
- Atopix Therapeutics Limited
- Richard Edward Armer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds having CRTH2 antagonist activity
- Patent number 8,536,158
- Issue date Sep 17, 2013
- Atopix Therapeutics Limited
- Richard Edward Armer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds having CRTH2 antagonist activity
- Patent number 7,919,512
- Issue date Apr 5, 2011
- Oxagen Limited
- Richard Edward Armer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds having CRTH2 antagonist activity
- Patent number 7,750,027
- Issue date Jul 6, 2010
- Oxagen Limited
- Richard Edward Armer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Compounds Having CRTH2 Antagonist Activity
- Publication number 20150246030
- Publication date Sep 3, 2015
- Atopix Therapeutics Limited
- Richard Edward ARMER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds Having CRTH2 Antagonist Activity
- Publication number 20140039012
- Publication date Feb 6, 2014
- Atopix Therapeutics Limited
- Richard Edward Armer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF LYSOSOMAL STORAGE DISORDERS AND OTHER PROTEOSTATIC DIS...
- Publication number 20110237538
- Publication date Sep 29, 2011
- SUMMIT CORPORATION PLC
- Olivier De Moor
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR THE TREATMENT OF FLAVIVIRAL INFECTIONS
- Publication number 20110195929
- Publication date Aug 11, 2011
- SUMMIT CORPORATION PLC
- Olivier De Moor
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds Having CRTH2 Antagonist Activity
- Publication number 20110142855
- Publication date Jun 16, 2011
- Oxagen Limited
- Richard Edward ARMER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds Having CRTH2 Antagonist Activity
- Publication number 20110123547
- Publication date May 26, 2011
- Oxagen Limited
- Richard Edward ARMER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR TREATING MUSCULAR DYSTROPHY
- Publication number 20100305120
- Publication date Dec 2, 2010
- BIOMARIN IGA LIMITED
- Graham Michael Wynne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds Having CRTH2 Antagonist Activity
- Publication number 20100266535
- Publication date Oct 21, 2010
- Oxagen Limited
- Richard Edward ARMER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds Having CRTH2 Antagonist Activity
- Publication number 20100063103
- Publication date Mar 11, 2010
- Oxagen Limited
- Richard Edward ARMER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds Having CRTH2 Antagonist Activity
- Publication number 20090186923
- Publication date Jul 23, 2009
- Richard Edward Armer
- C07 - ORGANIC CHEMISTRY

Frank Schroer

Person

Patents Grantslast 30 patents

Compounds having CRTH2 antagonist activity

Compounds having CRTH2 antagonist activity

Compounds having CRTH2 antagonist activity

Compounds having CRTH2 antagonist activity

Compounds having CRTH2 antagonist activity

Patents Applicationslast 30 patents

Compounds Having CRTH2 Antagonist Activity

Compounds Having CRTH2 Antagonist Activity

TREATMENT OF LYSOSOMAL STORAGE DISORDERS AND OTHER PROTEOSTATIC DIS...

COMPOUNDS FOR THE TREATMENT OF FLAVIVIRAL INFECTIONS

Compounds Having CRTH2 Antagonist Activity

Compounds Having CRTH2 Antagonist Activity

COMPOUNDS FOR TREATING MUSCULAR DYSTROPHY

Compounds Having CRTH2 Antagonist Activity

Compounds Having CRTH2 Antagonist Activity

Compounds Having CRTH2 Antagonist Activity